Pharmamarketeer

European Commission approves Bristol─Myers Squibb’s pending acquisition of Celgene

Bristol─Myers Squibb Company announced that the European Commission (EC) has granted unconditional approval of Bristol─Myers Squibb’s pending acquisition of Celgene Corporation.

Medhc-fases-banner
Advertentie(s)